Quick Answer
KAZIA THERAPEUTICS LTD reported Research And Development Expense of $7.33 million for the year ending 2025.
- KAZIA THERAPEUTICS LTD showed a decrease of -57.8% in Research And Development Expense from 2024 to 2025.
- This data is from KAZIA THERAPEUTICS LTD's annual report (Form 10-K), filed with the SEC on November 7, 2025.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), KAZIA THERAPEUTICS LTD's Research And Development Expense has declined by 26.0%.
- Historical annual values: Fiscal year 2025: $7.33 million | Fiscal year 2024: $17.38 million | Fiscal year 2023: $15.56 million | Fiscal year 2022: $20.17 million | Fiscal year 2021: $14.54 million | Fiscal year 2020: $9.49 million | Fiscal year 2019: $6.48 million | Fiscal year 2018: $9.77 million | Fiscal year 2017: $11.14 million | Fiscal year 2016: $9.89 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: